NEW YORK, Oct. 11, 2012 /PRNewswire/ -- Reportlinker.com
announces that a new market research report is available in its
catalogue:
Vaccines 2012 World Market Analysis, Key Players, Trends,
Pediatric and Adult Segments
http://www.reportlinker.com/p01008896/Vaccines-2012-World-Market-Analysis-Key-Players-Trends-Pediatric-and-Adult-Segments.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
This report examines the market for vaccines used in humans to
previous various types of disease. It covers only commercialized
vaccines and developmental vaccines for diseases that are already
vaccine-preventable; it does not cover emerging vaccines for
diseases that are not currently vaccine-preventable, such as
Alzheimer's disease, diabetes, Ebola infection, Epstein-Barr virus
(EBV) infection, ETEC infection, heart attach, Helicobacter pylori
infection, multiple sclerosis, Parkinson's disease, West Nile virus
(WNV) infection, etc.; vaccines that address these and other
not-yet-vaccine-preventable conditions are discussed in Kalorama's
new report, "What's Next in Vaccines."
The vaccine industry has seen changes in the past year, and
these are covered in this report Vaccines 2012: World Market
Analysis, Key Players, and Critical Trends in a Fast-Changing
Industry. The high growth rates and successful launch of
several products recently have kept interest in the global vaccine
market high. The global market for vaccines experienced strong
growth through 2011 and this is expected to continue through the
forecast period. Growth is being fueled by new product
introductions and rising usage in all regions.
Included in this report are current market size and forecast for
the following vaccines:
Pediatric Vaccines:
- Combinations
- Hepatitis
- HIB
- MMR
- Pneumococcal
- Poliovirus
- Varicella
- Other Pediatric
Adult Vaccines:
- Cervical Cancer
- Hepatitis
- Influenza
- Pneumococcal
- Travel; DT; Misc.
Kalorama has expanded the global perspective of this report in
this edition, including estimates of vaccine sales (pediatric and
adult segments) in the following regions:
- U.S.
- Rest of North Amer.
- South America
- Europe
- Japan
- India
- China
- Rest of World
Despite ongoing improvements in pediatric vaccination, it is
estimated that at least two million children die each year from
diseases that could have been prevented by already existing
vaccines. This problem is most significant in low income countries,
with the health disparity between rich and poor countries resulting
in average life spans of about 77 and 52 years, respectively. In
addition to this high death toll, millions more suffer disability
and illness because they have not been immunized. Adult
immunization is an important, but frequently overlooked, part of
patient care. Vaccination programs typically focus on children, yet
adults in industrialized countries are more likely to die as a
result of vaccine-preventable diseases than are children.
Key issues in the global vaccine market today include product
safety, refusal to immunize, supply shortages, the use of vaccines
to prevent pandemics and address bioterrorism, and innovations in
vaccine delivery systems.The following issues are discussed in this
report.
- Vaccine Safety
- Refusal to Immunize
- Obesity
- Post-Licensure Surveillance
- The Future of Vaccine Safety
- Vaccine Shortages
- Preventing Pandemics
- Project Bioshield Act
- National Bio and Agro-Defense Facility
- DNA Vaccination
- Mucosal Delivery
- Intranasal Delivery
- Vaccine Patches
- Vaccine Chips and Microneedles
- Innovations in Vaccine Production
- Nanoparticle Systems
- Cloning
Vaccination protects not only individuals, but also entire
communities from diseases spread by person-to-person
transmission.For example, vaccination can prevent about 50% of
deaths from pneumococcal disease and 80% of deaths from
influenza-related complications in the elderly. Pharmacoeconomic
studies have demonstrated the value of influenza and pneumococcal
vaccines; however, immunization rates for these diseases continue
to be low in the elderly populations. This report includes profiles
of the key players in vaccines, including:
- AlphaVax, Inc.
- Bavarian Nordic A/S
- Baxter Healthcare
- Bharat Biotech
- Crucell /Johnson & Johnson
- Emergent biosolutions
- GlaxoSmithKline
- Medimmune
- Merck & Co. Inc
- Novartis
- Sanofi Pasteur
- Pfizer
CHAPTER ONE: EXECUTIVE SUMMARY
- The Global Vaccine Industry
Scope and Methodology
Overview
Pediatric Preventative Vaccines
The Market
Adult Preventative Vaccines
The Market
Total Market
Issues and Trends
CHAPTER TWO: INTRODUCTION TO VACCINES
- A Brief History: The Development of Vaccines
Attenuated (Weakened) Live Viruses
Killed (Inactivated) Viruses
Toxoid Vaccines
Genetically Engineered/Modified Vaccines
Vaccine Approval Process
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
- Childhood Immunization in the United
States
Childhood Immunization Rates
Challenges to the Vaccine Delivery System
The Effect of U.S. Healthcare Reform
Recommended Childhood Immunization Schedule
State Immunization Recommendations
United Nations Initiatives
Pediatric Vaccine Products
BCG
Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
Haemophilus Influenzae Type B
Hepatitis A
Measles, Mumps and Rubella
Meningococcal Disease
Pneumococcal Conjugate
Rotavirus
Varicella
- Pediatric Vaccines in Development
- Cost of Vaccines in the United
States
- The World Market for Pediatric Preventive Vaccines
Total Market Size and Forecast
Hepatitis Vaccine Market
Haemophilus Influenzae Type B Vaccine Market
Measles, Mumps and Rubella Vaccines
Combination Vaccines Market
Pneumococcal Vaccine
Poliovirus Vaccine
Varicella Vaccines
Other Vaccines Market
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
- Adult Vaccine-Preventable Diseases: Facts and Figures
- Global Influenza Surveillance Program
U.S. Surveillance
Recommendations for Adult Immunizations
WHO International Health Regulations
Cervical Cancer
Cholera
Diphtheria-Tetanus
Hepatitis
Influenza
Japanese Encephalitis
Pneumococcal Disease
Rabies
Shingles
Typhoid Fever
Yellow Fever
- Adult Vaccines in Development
- The World Market for Adult Preventive Vaccines
Total Market Size and Forecast
Cervical Cancer Market
Hepatitis Market
1Influenza Vaccine Market
Travel, DT, and Miscellaneous Vaccine Market
CHAPTER FIVE: VACCINES MARKET SUMMARY
- Trends Driving the Vaccines Market
- Vaccine Market Competitors
CHAPTER SIX: ISSUES AND TRENDS
- Post-Licensure Surveillance
- The Vaccine Injury Compensation Program
- World Health Organization
- The Future of Vaccine Safety
- Preventing Shortages in the Developed Countries
- Preventing Shortages in Developing Nations
- U.S. National Vaccine Plan
- Vaccines and Bioterrorism
- National Bio and Agro-Defense Facility
- Vaccine Treatment and Evaluation Units
- Innovations in Vaccine Delivery Systems
- Vaccine Chips and Microneedles
- Innovations in Vaccine Production
CHAPTER SEVEN: COMPANY PROFILES
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
- Crucell /Johnson & Johnson
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
APPENDIX: COMPANY DIRECTORY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Figure 1-1: World Market for Pediatric Vaccines 2007-2016
Revenues (in millions)
- Figure 1-2: World Market for Adult Vaccines 2007-2016 Revenues
(in millions)
CHAPTER TWO: INTRODUCTION TO VACCINES
Table 2-1: Impact of Vaccines in the 20th Century Annual
Morbidity in the 20th Century vs 2011
- Exhibit 2-1: Attenuated Virus Production
- Table 2-2: Vaccine-Preventable Diseases, August 2012
- Table 2-3: VAERS Table of Reportable Events Following
Vaccination
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
Table 3-1: Global Immunization Rates by Vaccine Type 2010
- Table 3-2: Immunization Profile of the United States: Population by Age Group,
Number of Vaccine-Preventable Diseases Reported by Disease 1990 -
2010
- Table 3-3: U.S. Recommended Immunization Schedule for Children
Ages 0 Through 6 Years, 2012
- Table 3-4: U.S. Recommended Immunization Schedule for
Adolescents Age 7 to 18 Years, 2012
- Table 3-5: Selected Pediatric Vaccines in Development,
August 2012
- Table 3-6: World Market for Pediatric Vaccines by Type
(DTaP/DTP, Hep, HiB, MMR, Combinations, Pneumococcal, Polio,
Varicella, Others) 2007-2016 Revenues (in millions)
- Figure 3-1: Market Share of Pediatric Vaccines by Type
2011
- Figure 3-2: Market Share of Pediatric Vaccines, by Type
2016
- Table 3-7: World Market for Pediatric Vaccines by Region (U.S.,
North America, South America, EU, Japan, India,
China, Rest of World) 2006-2015
Revenues
- Table 3-8: World Pediatric Hepatitis Vaccine Market
2007-2016
- Table 3-9: World Hib Vaccine Market, 2007-2016
- Table 3-10: World MMR Vaccines Market 2007-2016
- Table 3-11: World Combination Vaccines Market 2007-2016
- Table 3-12: World Pediatric Pneumococcal Vaccine Market
2007-2016
- Table 3-13: World Poliovirus Vaccine Market 2007-2016
- Table 3-14: World Varicella Vaccine Market 2007-2016
- Table 3-15: World Pediatric Other Vaccines Market
2007-2016
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
- Table 4-1: Universal Adult Immunization Schedule 2012
- Table 4-2: Summary of Recommendations for Adult
Immunization
- Table 4-3: Initiatives to Require HPV Vaccination by U.S.
State, 2012
- Figure 4-1: U.S. Flu Season Severity from 2002 to 2012
- Table 4-4: WHO Pandemic Classification Schedule
- Table 4-5: Selected Adult Preventive Vaccines in Development,
2012
- Table 4-6: World Market for Adult Preventive Vaccines by Type
(Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2007-2016
Revenues
- Figure 4-1: Market Share of Adult Vaccines, by Type, 2011
- Figure 4-2: Market Share of Adult Vaccines, by Type, 2016
- Table 4-7: World Market for Adult Vaccines by Region (U.S.,
North America, South America, EU, Japan, India,
China, Rest of World) 2007-2016
Revenues
- Table 4-8: World Cervical CancerVaccine Market 2007-2016
- Table 4-9: World Hepatitis Vaccine Market 2007-2016
- Table 4-10: World Influenza Vaccine Market 2007-2016
- Table 4-11: 2011 Estimated Population by Region and Selected
Age Group
- Table 4-12: World Pneumococcal Vaccine Market 2007-2016
- Table 4-13: World Travel; Diphtheria-Tetanus; Miscellaneous
Vaccines Market 2007-2016
CHAPTER FIVE: VACCINES MARKET SUMMARY
Figure 5-1: Sales Growth of Vaccines vs. Pharmaceuticals
2007-2016
- Table 5-1: The World Vaccines Market by Vaccine Type 2007-2016
Revenues
- Figure 5-2: World Market for Vaccines Share by Type, 2007, 2011
and 2016
- Table 5-2: The World Vaccines Market by Region (U.S.,
North America, SouthAmerica, EU,
Japan, India, China,
ROW) 2007-2016 Revenues
- Table 5-3: Major Manufacturers' Shares of the World Vaccine
Market, 2011
- Figure 5-3: 2011 World Vaccines Market Share, by Leading
Competitors
- Table 5-4: Major Manufacturer's Shares of the World Pediatric
Vaccine Market 2011
- Figure 5-5: Market Share of Pediatric Vaccines Market,
2011
- Table 5-5: Major Manufacturer's Shares of the World Adult
Vaccine Market 2011
- Figure 5-6: Market Share of Adult Vaccines Market 2011
CHAPTER SIX: ISSUES AND TRENDS
Table 6-1: Selected Companies/Laboratories Developing Biodefense
Vaccines
To order this report:
Drug_and_Medication Industry: Vaccines 2012
World Market Analysis, Key Players, Trends, Pediatric and Adult
Segments
__________________________
Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker